πŸ‡ΊπŸ‡Έ FDA
Patent

US 11564992

Nucleophilic catalysts for oxime linkage

granted A61KA61K47/54A61K47/542

Quick answer

US patent 11564992 (Nucleophilic catalysts for oxime linkage) held by Takeda Pharmaceutical Company Limited expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K47/54, A61K47/542, A61K47/59, A61K47/60